Previous studies have shown an increased risk for a range of mental health issues in children 25 born to both younger and older parents compared to children of average-aged parents. However, 26 until recently, it was not clear if these increased risks are due to psychosocial factors associated 27 with age or if parents at higher genetic risk for psychiatric disorders tend to have children at an 28 earlier or later age. We previously used a novel design to reveal a latent mechanism of genetic 29 association between schizophrenia and age of mothers at the birth of their first child (AFB). 30
INTRODUCTION 45
An increased risk for a range of mental health issues in children born to both younger and older 46 parents compared to children of average-aged parents has been reported in many studies 1-8 , with 47 particular focus on risk of schizophrenia (SCZ) in children associated with parental age 9-12 . A 48 recent comprehensive analysis using family data extracted from the Danish Psychiatric Central 49
Register reported a relationship between mother's age and risk of schizophrenia in her 50 offspring 13 . They showed that there was higher risk in children of younger and older mothers 51 compared to those of intermediate age (25-29 yearsi.e. a U-shaped relationship between 52 maternal age and risk of SCZ in offspring), but it was unclear if this was due to psychosocial 53 factors associated with maternal age or if mothers at higher genetic risk for SCZ tend to have 54 children at an earlier or later age. Moreover, the very high correlation in spousal ages makes 55 paternal and maternal contributions to this relationship difficult to disentangle. A number of 56 possible latent mechanisms behind these epidemiological observations have been proposed 14 , 57 including shared genetic risk factors between parents and offspring 15, 16 (Figure 1) . A better 58 understanding of factors contributing to the relationship between parental age and risk of 59 psychiatric disorders is important for informing any future public health initiatives targeting this 60 relationship. 61 We have previously reported evidence for a genetic relationship between maternal age at first 66 birth (AFB) and risk of SCZ 17 , as illustrated in red in Figure 1 . We employed a novel design that 67 directly tests the genetic risk of schizophrenia in mothers depending on AFB. In all previous 68 study designs the psychiatric disorder was measured in the child, and hence the relationship with 69 AFB in the mother was confounded with characteristics of the father. Here, and in our previous 70 study we examine the relationship between SCZ and AFB by using a genetic predictor of 71 schizophrenia in the mother. The analyses use community samples of women enrolled in 72 research studies that were not enriched for psychiatric disorders (< 1% for diagnosis with 73 schizophrenia). The genetic predictor for schizophrenia can be calculated for all women in the 74 studies as a function (such as weighted sum) of the schizophrenia risk alleles they carry, with the 75 risk alleles identified in published genome-wide association studies (GWAS) as having increased 76 frequencies in SCZ cases compared to controls. A woman's genetic risk for schizophrenia is 77 solely a function of her DNA, which she received independently of the characteristics of her 78 partner. Hence, a benefit of this novel design is that the inferred association is not confounded by 79 artefactual or non-genetic association(s) such as increased SCZ risk in offspring due to maternal 80 environmental effects or by confounding with father's age. We showed that the U-shaped 81 relationship (between maternal age at birth and SCZ risk in offspring) observed in 82 epidemiological studies was also observed when considering predicted genetic risk for SCZ as a 83 function of AFB in healthy women 13, 17 . 84
85
In this study, we replicate and extend our earlier findings 17 using the UK Biobank data in which 86 community samples of women have been measured for AFB. First, we confirm that SCZ 87 polygenic risk score (PRS) for women in the UK Biobank with a record of AFB (N = 38,892) 88 significantly predicts the U-shaped relationship found in McGrath et al. 13 , thereby replicating the 89 results in Mehta et al. 17 . Second, we test if there is a genetic heterogeneity for AFB between 90 younger and older AFB groups. Third, we estimate the genetic correlation between SCZ and 91 AFB in younger and older AFB groups. 92 93 94
RESULTS 95
Overview 96
In total, 41,630 SCZ GWAS samples including 18,957 cases and 22,673 controls from 33 97 cohorts were used in the current study (Table S1 ), which were the same data used in Mehta et 98 al. 17 . For the UK Biobank sample, 38,892 women were used in current study. The distribution of 99 AFB, age at interview, and year of birth for the UK Biobank data after QC is shown in Figure  100 S1. In total, 518,992 SNPs passed the quality control criteria and were in common across the 101 SCZ and UK Biobank samples. The distribution of MAF is shown in Figure S2 . Figure S3 shows 102 that there were no closely related individuals in the UK Biobank and SCZ case-control data sets, 103 making sure that the two data sets were independent. 104
We estimated SCZ polygenic risk cores (PRS) for each individual in the UK Biobank sample, 105 using the SCZ GWAS as a reference data set (see Methods). We used both the standard genetic 106 profile score approach 18 (PRS-score) and the theoretically superior method of Genomic Best 107
Linear Unbiased Prediction (PRS-GBLUP). We assessed the U-shaped relationship between 108 AFB and SCZ PRS for the UK Biobank sample. We emphasize that in this novel design, it was 109 not necessary to measure SCZ risk in offspring, and in our strategy potential confounding due to 110 a correlation between paternal and maternal age was mostly removed. 111
Subsequently, we estimated SNP-heritability and genetic correlation between AFB and SCZ. 112
Because of the non-linear relationship (U-shape), we divided the UK Biobank sample into two 113 groups with younger and older AFB. We assessed if the younger and older AFB groups were 114 genetically heterogeneous, and if there is any significant genetic correlation between SCZ and 115 each of the younger and older AFB groups. 116
Relationship between SCZ PRS and AFB 118
Consistent with McGrath et al. 13 and replicating the findings in Mehta et al. 17 , a U-shaped 119 relationship was observed between AFB and SCZ PRS-GBLUP ( Figure 2 ). The mean SCZ PRS-120 GBLUP in women with early AFB (<20 years) was significantly higher than that in women with 121 intermediate AFB (P= 2.2E-02 for AFB between 20 to < 25 years, P=1.2E-05 for AFB between 122 25 to < 30 years, P=2.0E-02 for AFB between 30 to < 35 years, in Table S2 ), but not in women 123 with high AFB (P=4.9E-01 for AFB ≥35 years). The mean SCZ PRS-GBLUP in women with 124 AFB between 25 to < 30 years was significantly lower than that in women with AFB between 20 125 to < 25 years (P=2.0E-03). Our results confirmed the findings in Mehta et al. 17 and with stronger 126 significance, both when PRS was calculated using GBLUP (PRS-GBLUP) and when using 127 conventional profile scoring based on GWAS summary statistics from the SCZ GWAS data 128 (PRS-score) ( Figure S4 and Table S2 ). We also confirmed that the U-shaped relationship was 129 replicated with estimated SNP effects from the full SCZ GWAS study (PRS-scorePGC) (See 130 Figure S4 and Table S3 ), although these results could be biased due to possible sample overlap 131 or the presence of relatives between the UK Biobank and the full SCZ data. 132 Figure 3 shows that the response variable was significantly predicted by SCZ PRS for the 141 group with the full range of AFB (P-value = 1.12E-05 for PRS-GBLUP, and P-value = 3.53E-07 142 for PRS-score and P-value = 3.08E-06 for PRS-scorePGC) and the subgroup with AFB younger 143 than 26 (P-value = 4.71E-06, 6.06E-08 and 2.45E-06 for PRS-GBLUP, PRS-score and PRS-144 scorePGC, respectively), but not for the subgroup with AFB older than 26. The prediction with 145 PRS-score was stronger than that with PRS-scorePGC, and both stronger than that with PRS-146 GBLUP. 147 Even with this conservative model, our results for the group with full range of AFB and the 165 subgroup with AFB younger than 26 remained significant ( Figure S5 and Table S4 ), albeit with 166 reduced effect size and significance. The reduced significance might be partly explained by the 167 reduced sample size (i.e. for full range of AFB, N= 38,892 in the base model and 31,848 in 168 model adjusted for education and income; see Table S4 ). In sensitivity analyses we also 169 restricted the sample to those recruited at age ≥45 years (N=35,451), which included the vast 170 majority of women with a record of AFB, so that results were not biased by the exclusion of 171 women with no reported AFB measure. We found that there was no substantive difference in our 172 results despite the reduced sample size (Table S4 vs. Table S5 ). 173
The UK Biobank sample was divided into two subgroups born before or after 1945, a boundary 174 of postponement of AFB based on the theory of the second democratic transition 19 . For 175 individuals born after 1945, PRS-GBLUP significantly predicted the response variable for the 176 group with the full range of AFB and the subgroup with AFB younger than 26, even after 177 adjusting for socioeconomic status, and smoking and alcohol drinker status, but not for the 178 subgroup with older AFB. For individuals born before 1945, PRS-GBLUP did not significantly 179 predict the response variable for the group with the full range of AFB (P-value = 6.52E-02) nor 180 the subgroup with AFB younger or older than 26 (P-value = 4.99E-02 or 4.38E-01) (Table S6) . 181
Our results agreed with the results of Mehta et al. 17 in that SCZ PRS of women significantly 182 predicted the response variable for the group with the full range of AFB and the subgroup with 183 AFB younger than 26. The signals became stronger for the individuals born after year 1945. 184
Genetic correlation between AFB and SCZ 186
Given that the AFB for women in the UK Biobank data was significantly predicted by PRS-187 GBLUP (P-value=1.12E-05 and R 2 =4.96E-04 in Table S4 ), it was of interest to estimate the 188 genetic correlation between AFB and SCZ, which is the scaled proportion of variance that AFB 189 and SCZ share due to genetic factors. errors. In the model, the AFB phenotypes were adjusted for age at interview, year of birth, 201 assessment center at which participant consented, genotype batch and the first 20 principal 202 components. And, the SCZ phenotypes were adjusted for sex, cohorts and the first 20 principal 203 components. The sample size for group AFB ≥ 26 was 17,598 and for group AFB<26 was 204 21,294, and for group SCZ was 41,630. 205
206
The estimated genetic correlation between the younger and older AFB groups was significantly 207 less than 1 (rg=0.47, SE=0.19, P-value=3.45E-03, in Table S7 ), indicating that younger and older 208 AFB were genetically heterogeneous in the UK Biobank (Figure 4 left panel) . We demonstrate 209 that a truncated selection had little impact on the estimation of the genetic correlation 20 210 (Supplemental Notes 1 and 2 and Figures S6 and S7) . Further, the estimated genetic correlation 211 between SCZ and AFB in the younger AFB group was -0.16 (SE=0.04) and that between SCZ 212 and AFB in the older AFB group was 0.14 (SE=0.08) (Figure 4 left panel) . 213
In sensitivity analyses, education level, income level, smoking and alcohol drinker status were 214 additionally used to adjust the phenotypes in the GREML analyses to see if those factors change 215 the estimates. Figure S8 shows that the estimates and their significance were slightly reduced, 216 which could be partly explained by the decrease of sample size (N=38,892 in the base model 217 versus 31,848 in the model adjusted for education and income; see Table S7 ). 218
219
In addition to GREML, linkage disequilibrium score regression (LDSC) 4,21 was applied to 220 estimate the genetic correlation between SCZ and younger and older AFB (Table S8 ). As 221 recommended by the LDSC papers 4,21 , pre-estimated LD scores from the 1000 Genome 222 reference sample without constraining the intercept of regression were applied to the QCed 223 GWAS data and full GWAS summary results. However, we could access individual genotype 224 data and it was clearly known that there was no overlapping sample and no high relatedness in 225 the QCed GWAS data for which we would be able to use LD scores estimated based on the 226 actual genotype data as well as to constrain the intercept as zero. As reported 4,21 , it was observed 227 from simulations (Supplemental Note 3) that if there was no overlapping sample, LDSC with 228 constraining the intercept as zero gave the most accurate estimate with the least standard error 229 ( Figure S9 ). In the real data analyses, Table S8 showed that LDSC with constraining the 230 intercept as zero gave similar estimates and standard errors, compared to those from GREML 231 when using the QCed data. When explicitly estimating the intercept, the standard errors became 232 large; therefore the precision of estimates might be decreased (Table S8 ). When using the full 233 GWAS summary, LDSC gave similar estimates but larger standard errors, compared to GREML 234 estimates, although a larger SCZ sample size was used for LDSC analyses (77,096 for LDSC vs. 235 41,630 for GREML). 236
DISCUSSION 238
Parental age has been consistently associated with an increased risk of SCZ in offspring 9-239 13,15,16,22,23 , but it is well known that traditional epidemiological study designs, based on data 240 measured for parental age and SCZ status in their offspring, have limitations with respect to 241 disentangling genetic effects from non-genetic confounding effects such as common and residual 242 environmental effects (Figure 1) . The elevated risk of SCZ associated with parental age extends 243 to children of both younger and older parents, compared to children of average aged parents -244 i.e. a U-shaped relationship 13 . The most widely accepted mechanism, in the case of delayed 245 parenthood, is a causal relationship due to the accumulation of de novo mutations with age (e.g. 246
Kong et al. 24 ), although this cannot explain increased risk in offspring of younger parents. This 247 hypothesis is biologically plausible 25-28 , but Gratten et al. 29 have shown using theory and 248 simulations that paternal age-related de novo mutations are unlikely to be the major causal factor 249 responsible for increased risk of SCZ in offspring. Instead, they argued that increased risk of 250 SCZ in offspring of older fathers could be due to genetic overlap between risk of SCZ and 251 delayed parenthood. This finding is consistent with epidemiological studies showing that 252 paternal age at first child, as opposed to paternal age at conception, accounts for the increased 253 risk of SCZ in the children of older fathers (i.e. arguing against a direct causal role for age-254 related de novo mutations) 15, 16 . Notably, this mechanism of genetic overlap between parental age 255 and SCZ applies equally well to offspring SCZ risk associated with early parenthood. and AFB in women that is free of many of the potential confounders present in epidemiological 259 study designs (e.g. poor maternity skill, psychosocial factors and shared environmental factors). 260
Specifically, they used SNP effects obtained using SCZ case-control data to estimate genetic risk 261 of SCZ in a general community sample of women measured for AFB, finding significant 262 evidence for pleiotropy between SCZ and AFB. In this analysis, we replicated their results in a 263 much larger and independent community sample, the UK Biobank study. We confirmed the U-264 shaped relationship between AFB and SCZ PRS reported by Mehta et al. 17 (Figures 2 and 3) , and 265 provided evidence of genetic overlap between SCZ and AFB in women. The large number of 266 samples in the UK Biobank made it possible to also estimate genetic variance and covariance 267 between SCZ and AFB using a linear mixed model, showing that the traits of younger and older 268 AFB are genetically heterogeneous (Figure 4 or Table S7 ). The genetic correlation between SCZ 269 and AFB in women with AFB<26 was -0.16 (SE = 0.04), which was significantly different from 270 zero (Figure 4) . 271
272
In linear prediction, results from PRS-score were similar to or more significant than those from 273 PRS-scorePGC (Table S4 ). This is noteworthy because PRS-scorePGC was based on the GWAS 274 summary statistics from the full PGC SCZ GWAS (33,640 cases, 43,456 controls), which is a 275 larger sample than that used to generate PRS-score (individual-level genotype data on 18,957 276 cases, 22,673 controls). However, publicly available GWAS summary statistics such as those 277 used for PRS-scorePGC provide incomplete information about sample overlap or pairwise 278 relationships between data sets, either of which could introduce biases or influence statistical 279 significance due to non-independence of samples. There is an approach or strategy for 280 relatedness QC without accessing individual genotypes 30 , however, it is not immediately 281 applicable to the full PGC data. We hypothesize that the superior performance of PRS-score in 282 our analysis, despite smaller sample size than PRS-scorePGC (which is explained by restrictions 283 on data access for individual-level genotype data), reflects the very stringent QC we applied to 284 the data, including on relatedness. 285 286 Estimated genetic correlations and their standard errors based on GREML and LDSC were very 287 similar (Table S8 ), but only when the intercept of the LDSC was constrained, which requires the 288 strong assumption of no overlapping samples, and only when LD scores were calculated from 289 the actual sample, which is usually not possible when using GWAS summary statistics. We also 290 observed this phenomenon in our results based on simulated data (Supplemental Note 3 and 291 Figure S9 ). These observations are in line with the statement in Bulik-Sullivan et al. 21 , that 292 standard errors are sacrificed to achieve unbiased genetic correlation and the availability of 293 individual-level genotype data was the most preferable scenario. Nevertheless, the estimated genetic correlations between SCZ, younger AFB and older AFB were consistent using two 295 different approaches, i.e. GREML and LDSC (Table S8) . 296
297
In summary, this study replicated previously reported evidence for significant genetic overlap 298 between risk of SCZ and AFB in women using an independent target sample from the UK 299
Biobank. We further showed that AFB in women is genetically heterogeneous (comparing 300 younger to older AFB) and that there is a significant genetic correlation between SCZ and AFB. 301
Conducting parallel analyses for AFB in men is of great interest but these data are less easily 302 available and AFB has not been recorded for men in the UK Biobank. Our results suggest that 303 early, and perhaps also late, age at first birth in women is associated with increased genetic risk 304 for schizophrenia. These findings contribute new insights into factors contributing to the 305 complex bio-social risk architecture underpinning the association between parental age and 306 offspring mental health. 307
308

METHODS AND MATERIALS 309
Participants and quality control 310
Schizophrenia (SCZ) sample 311
Genome-wide association data were available from 18,987 SCZ cases and 22,673 controls from 312 the second phase of the Psychiatric Genomics Consortium (PGC) 31 with quality control (QC) 313 applied as described in Mehta et al. 17 . Briefly, the SNP quality control and imputation process 314 were performed by PGC 31 . The raw genotype data were imputed with IMPUTE2/SHAPEIT 32,33 315 using the full 1000 Genomes Project dataset 34 as the reference set. Post-imputation quality 316 control was performed in each cohort before merging the genotype data across all cohorts, as described elsewhere 17, 31 . As in Mehta et al. 17 , we used HapMap3 SNPs that were reliable in 318 estimating (shared) genetic architecture between complex traits [35] [36] [37] . Furthermore, SNPs with call 319 rate < 0.9, individuals with call rate < 0.9 were excluded. This less stringent QC for call rate was 320 because SNP and individual QC had been already done by the PGC. After this QC, 688,145 321 SNPs and 41,630 individuals were remained and used to combine with the UK Biobank sample. where y is a vector of phenotypic data (i.e. 1s for SCZ cases, 0s for SCZ controls and missing for 353 UK Biobank individuals), represents vectors of fixed effects including sex, cohort and 20 354 ancestry principal components (PCs), is the vector of SCZ PRS, and e is the vector of 355 residuals. and are design matrices to allocate effects to phenotypic data. It is assumed that u 356 is normally distributed as (0, 2 ), where is the genomic relationship matrix constructed as 357 described in Yang et al. 41 and 2 is the additive genetic variance, and e is normally distributed as 358 (0, 2 ), where is an identify matrix and 2 is the residual variance. GBLUP was performed 359 using GCTA 41 or MTG2 42,43 so that a subset of for the UK Biobank sample could be inferred 360 based on the phenotypes of the SCZ sample and the genomic relationships between the two data 361 sets. Mean SCZ PRS in the UK Biobank individuals grouped by their AFB was estimated to 362 assess the previously reported U-shaped relationship 13, 17 . GBLUP provides more accurate PRS 363 (PRS-GBLUP) under a polygenic genetic architecture than the more standard genetic profile 364 score approach 18 , but for comparison we also calculated PRS by the standard method (PRS-365 score). To estimate SCZ risk SNP effects, an association test was conducted with PLINK 1.9 44 366 using the same SCZ GWAS data used in the GBLUP analyses, with phenotypes adjusted for sex, 367 cohort and 20 PCs. PRS-scores for individuals in the UK Biobank sample were generated by 368 summing the count of SCZ risk alleles weighted by the SNP effects estimated from the 369 association test. In addition to PRS-score, we used the estimated SNP effects from the full SCZ 370 shaped relationship between risk of SCZ in children and maternal age at birth. The resulting 378 equation from the U-shaped relationship (z = 2.7214 -0.1105X+0.0018X 2 ) can be applied to data 379 of age at first birth of women to generate predictors of risk of SCZ in their children 17 . We did not 380 consider the second model in Mehta et al. 17 that was adjusted for partner's ages because the 381 model was shown to be over-corrected 17 . We calculated the response variable (z) in the UK 382 Biobank sample from the recorded age at first birth (X) and this was used as the y-variable in 383 analyses regressing on either PRS-GBLUP, PRS-score or PRS-scorePGC and including age at 384 interview, assessment center at which participant consented, genotype batch, year of birth and 385 the first 20 PCs as covariates. Socioeconomic status (i.e. education and income level) 45 or smoking and alcohol drinker status were additionally used to adjust the response variable in 387 sensitivity analyses ( Figure S1 ). Linear models were applied to the group with the full range of 388 AFB records, the subgroup with AFB younger than 26 years (< 26), and the subgroup with AFB 389 at or older than 26 (≥ 26), respectively, where the value of 26 is the mean of AFB in the UK 390 Biobank sample. From the model, the coefficient of determination (R 2 ) and P-value against the 391 null hypothesis (i.e. SCZ PRS of women is not a predictor of AFB) were estimated. 392 393
Genomic residual maximum likelihood (GREML) 394
It is of interest to test if AFB in women is a genetically heterogeneous trait, for instance by 395 estimating the genetic correlation between younger and older AFB groups. If the genetic 396 correlation is significantly different from 1, it would imply that the causal variants and/or their 397 effect sizes differ between younger and older AFB. Moreover, it would be interesting to estimate 398 genetic correlations between SCZ case-control data and younger or older AFB groups. The UK 399
Biobank data were divided into two groups by younger (< 26) and older AFB (≥ 26). Then, 400 three-variate linear mixed model analysis was conducted to estimate genetic variance and 401 covariance between SCZ case-control data, and younger and older AFB groups. The model can 402 be written as 403 y 1 = X 1 b 1 + Z 1 g 1 + e 1 for SCZ sample 404 y 2 = X 2 b 2 + Z 2 g 2 + e 2 for UK Biobank sample with AFB < 26 405 y 3 = X 3 b 3 + Z 3 g 3 + e 3 for UK Biobank sample with AFB ≥ 26 406 where y are three column vectors of phenotypic observations (one for each data set or group, i.e. 407 SCZ case-control data set, UK Biobank AFB < 26 and UK Biobank AFB ≥ 26). For SCZ case-408 control data, pre-adjusted phenotypes corrected for sex, cohort and 20 PCs were used. For the 409 UK Biobank sample, the AFB phenotypes were pre-adjusted for sex, age at interview, year of 410 birth, assessment center, genotype batch and 20 PCs. Again, other possible confounding factors 411 such as socioeconomic status, and smoking and alcohol drinker status were additionally 412 controlled in sensitivity analyses to check if the estimates were substantially changed. The 413 GREML analyses were conducted with GCTA 41 or MTG2 42,43 to estimate pairwise genetic 414 correlations among the three data sets; SCZ data, and younger AFB and older AFB. 415 416
